Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Dmitriy Petrov, Narhari Timilshina, Efthymios Papadopoulos & Shabbir M.H Alibhai. (2022) Performance of the frailty index in predicting complete remission, intensive care unit admission, and overall mortality in older and younger patients with acute myeloid leukemia receiving intensive chemotherapy. Leukemia & Lymphoma 63:9, pages 2189-2196.
Read now
Read now
Mansour Alfayez & Gautam Borthakur. (2018) Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges. Expert Review of Hematology 11:5, pages 373-389.
Read now
Read now
Shin-ichiro Fujiwara, Kazuo Muroi, Chihiro Yamamoto, Kaoru Hatano, Kiyoshi Okazuka, Kazuya Sato, Iekuni Oh, Ken Ohmine, Takahiro Suzuki & Keiya Ozawa. (2017) CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia. Hematology 22:6, pages 347-353.
Read now
Read now
Alessandro Isidori, Federica Loscocco & Giuseppe Visani. (2016) AML therapy in the elderly: a time for a change. Expert Opinion on Drug Safety 15:7, pages 891-892.
Read now
Read now
Daisuke Araki, Megan Othus, Roland B. Walter, Pamela S. Becker, Vicky Sandhu & Elihu H. Estey. (2016) Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?. Leukemia & Lymphoma 57:5, pages 1205-1207.
Read now
Read now
Naval Daver, Jorge Cortes, Hagop Kantarjian & Farhad Ravandi. (2016) Acute myeloid leukemia: advancing clinical trials and promising therapeutics. Expert Review of Hematology 9:5, pages 433-445.
Read now
Read now
Jie Jin, Jian Chen, Shanshan Suo, Wenbin Qian, Haitao Meng, Wenyuan Mai, Hongyan Tong, Jian Huang, Wenjuan Yu, Juyin Wei & Yinjun Lou. (2015) Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia. Leukemia & Lymphoma 56:6, pages 1691-1697.
Read now
Read now
Articles from other publishers (18)
Alexandra Teixeira, Luís Carreira, Sara Abalde-Cela, Belém Sampaio-Marques, Anabela C. Areias, Paula Ludovico & Lorena Diéguez. (2023) Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review. Cancers 15:5, pages 1362.
Crossref
Crossref
Chen Wang, Ravi Nistala, Min Cao, Yi Pan, Madelaine Behrens, Donald Doll, Richard D. Hammer, Puja Nistala, Hui-Ming Chang, Edward T.H. Yeh & XunLei Kang. (2023) Dipeptidylpeptidase 4 promotes survival and stemness of acute myeloid leukemia stem cells. Cell Reports 42:2, pages 112105.
Crossref
Crossref
Meng‐Di Wu, Yuan‐Ying Zhang, Shu‐Ying Yi, Bei‐Bei Sun, Jing Lan, Han‐Ming Jiang & Gang‐Ping Hao. (2022) Acetylshikonin induces autophagy‐dependent apoptosis through the key LKB1‐AMPK and PI3K/Akt‐regulated mTOR signalling pathways in HL‐60 cells. Journal of Cellular and Molecular Medicine 26:5, pages 1606-1620.
Crossref
Crossref
Kwai Han Yoo, Hyeoung-Joon Kim, Yoo Hong Min, Dae-Sik Hong, Won Sik Lee, Hee-Je Kim, Ho-Jin Shin, Yong Park, Je-Hwan Lee & Hawk Kim. (2021) Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry. PLOS ONE 16:5, pages e0251011.
Crossref
Crossref
Kwai Han Yoo, Jinhyun Cho, Boram Han, Se Hyung Kim, Dong-Yeop Shin, Junshik Hong, Hawk Kim, Hyo Jung Kim, Dae young Zang, Sung-Soo Yoon, Jong-Youl Jin, Jae Hoon Lee, Dae-Sik Hong & Seong Kyu Park. (2020) Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults. PLOS ONE 15:8, pages e0235503.
Crossref
Crossref
Yulin Li, Daniel Thomas, Anja Deutzmann, Ravindra Majeti, Dean W. Felsher & David L. Dill. (2019) Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index. Scientific Reports 9:1.
Crossref
Crossref
Deepshi Thakral & Ritu Gupta. 2019. Hematopathology. Hematopathology
163
182
.
Eirik Joakim Tranvåg, Ole Frithjof Norheim & Trygve Ottersen. (2018) Clinical decision making in cancer care: a review of current and future roles of patient age. BMC Cancer 18:1.
Crossref
Crossref
Susan Storey, Tamryn Fowler Gray & Ashley Leak Bryant. (2017) Comorbidity, Physical Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia. Current Geriatrics Reports 6:4, pages 247-254.
Crossref
Crossref
Maël Heiblig, Mohamed Elhamri, Caroline Le Jeune, Marie-Charlotte Laude, Alexandre Deloire, Eric Wattel, Gilles Salles & Xavier Thomas. (2017) Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors. European Journal of Haematology 98:2, pages 134-141.
Crossref
Crossref
Yahui Ding, Huier Gao, Yu Zhang, Ye Li, Neil Vasdev, Yingdai Gao, Yue Chen & Quan Zhang. (2016) Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
N Daver, H Kantarjian, F Ravandi, E Estey, X Wang, G Garcia-Manero, E Jabbour, M Konopleva, S O'Brien, S Verstovsek, T Kadia, C Dinardo, S Pierce, X Huang, N Pemmaraju, M Diaz-Pines-Mateo, J Cortes & G Borthakur. (2015) A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome. Leukemia 30:2, pages 268-273.
Crossref
Crossref
Honglei Tu, Bo Lei, Shan Meng, Hailing Liu, Yongchang Wei, Aili He, Wanggang Zhang & Fuling Zhou. (2016) Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia. Evidence-Based Complementary and Alternative Medicine 2016, pages 1-7.
Crossref
Crossref
Mario Delia, Paola Carluccio, Caterina Buquicchio, Carolina Vergine, Giuseppina Greco, Barbara Amurri, Angela Melpignano, Lorella Melillo, Nicola Cascavilla, Attilio Guarini, Silvana Capalbo, Giuseppe Tarantini, Patrizio Mazza, Vincenzo Pavone, Nicola Di Renzo & Giorgina Specchia. (2015) Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP). Leukemia Research 39:11, pages 1166-1171.
Crossref
Crossref
Nianxi Zhao, Sung-Nan Pei, Jianjun Qi, Zihua Zeng, Swaminathan P. Iyer, Pei Lin, Ching-Hsuan Tung & Youli Zu. (2015) Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia. Biomaterials 67, pages 42-51.
Crossref
Crossref
Steffan T. Nawrocki, Kevin R. Kelly, Peter G. Smith, Mignon Keaton, Hetty Carraway, Mikkael A. Sekeres, Jaroslaw P. Maciejewski & Jennifer S. Carew. (2015) The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine. Clinical Cancer Research 21:2, pages 439-447.
Crossref
Crossref
Eunice S. Wang. (2014) Treating acute myeloid leukemia in older adults. Hematology 2014:1, pages 14-20.
Crossref
Crossref
Chen Wang, Ravi Nistala, Min Cao, Madelaine Behrens, Donald Doll, Richard D. Hammer, Puja Nistala, Hui-Ming Chang, Edward T.H. Yeh & XunLei Kang. (2022) Dependence of Acute Myeloid Leukemia Development on Membrane Protein Dipeptidyl Peptidase 4. SSRN Electronic Journal.
Crossref
Crossref